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Circulating hormones and local biotransformation of steroid
precursors are both sources of estrogen in human mammary
tissue. Estrone-3-sulfate (E1S) is an important estrogenic form
in premenopausal women, and dehydroepiandrosterone sul-
fate (DHEAS) constitutes a major adrenal precursor. Mem-
brane transport systems that govern delivery of these anionic
steroid conjugates to the mammary gland were investigated.
RNA was screened by RT-PCR and Northern blotting for ex-
pression of organic anion transporting polypeptide (OATP)
(solute carrier family 21A) and organic anion transporter
(OAT) (solute carrier family 22A) gene families. OATP-B
(SLC21A9) was the major carrier expressed; OATP-D
(SLC21A11) and OATP-E (SLC21A12) were less abundant. In
normal sections, OATP-B immunolocalized to the myoepithe-
lium that surrounds the ductal epithelial cells. In invasive
carcinoma, ductal epithelial cells were positive. OATP-B was
characterized in stable transfected Chinese hamster ovary
cells. E1S affinity constant (Km) [Km  5 mol/liter, maximum
velocity (Vmax) Vmax  777 pmol/mgmin] and DHEAS (Km  9
mol/liter, Vmax 85 pmol/mgmin) were substrates. The pros-
taglandins (PG) A1 and PGA2 stimulated uptake of E1S and
DHEAS by increasing Vmax 2-fold but not changing Km. The
effect of PGA was selectively blocked by the lipophilic thiol
reagent N-ethylmaleimide but not by the hydrophilic acet-
amido-4(iodoacetyl)aminostilbene-2,2-disulfonic acid, sug-
gesting an interaction between the electrophilic cyclopen-
tenone ring and specific cysteine residues of OATP-B. (J Clin
Endocrinol Metab 88: 3902–3912, 2003)
THE MAMMARY GLAND is an estrogen-responsive tis-sue. Estrogens act through the estrogen receptors to
direct normal lobular development, regulate epithelial cell
growth, and increase the expression of steroid hormone me-
tabolizing enzymes (1, 2). Moreover, estrogen is the most
important etiological factor that supports the growth of es-
trogen receptor-positive breast tumors. One source of estro-
gen is local biosynthesis within the epithelial cells and stro-
mal fibroblasts from the adrenally derived precursors,
dehydroepiandrostenedione (DHEA) and androstenedione.
DHEA circulates primarily in its 3-sulfate form, dehy-
droepiandrosterone sulfate (DHEAS), and serves as the
principal conjugated prohormone for the biosynthesis of
both estrogenic [17-estradiol (E2), estrone (E1), and 5-
androstenediol] and androgenic (testosterone) steroids in
peripheral tissues (3, 4). The enzymes that catalyze the
desulfation of DHEAS, the subsequent 3 oxidation of
DHEA to androstenedione and 17 reduction of andro-
stenedione to testosterone, as well as the aromatization of
testosterone and androstenedione into E2 and E1, respec-
tively, have all been detected in breast tissue and studied
in breast cancer cell lines (5–7). A second source of estro-
gen are the circulating hormones, the composition and
concentration of which vary widely as a function of age.
In premenopausal women, estrone 3-sulfate (E1S) is the
major form, and its cyclical concentrations range from 2.5
to 15 nmol/liter (8, 9). In breast tissue, E1S is sequentially
desulfated and reduced to the more potent E2 (7, 10). In
postmenopausal women, the estrogen concentrations
decline, although adrenally derived DHEAS levels
can remain above 2–3 mol/liter even into the seventh
decade (11).
The activities of several key enzymes necessary for in situ
estrogen production are higher in tumors compared with
normal tissue (12, 13), in keeping with the widely held tenet
that sex steroid exposure is a strong risk factor for breast
cancer. There are also epidemiological data to support an
association between the circulating concentrations of hor-
mones and prohormones, including E1S and DHEAS, and the
eventual risk of developing breast cancer, especially in the
postmenopausal years (14, 15). This link implies that steroids
in their sulfated, anionic form gain access to the intracellular
milieu and can determine the extent of exposure to down-
stream, biologically active hormones. Sulfated steroid con-
jugates carry a net negative charge at physiological pH levels,
and as such, their transfer across cell membranes is carrier
mediated. Steroid sulfates have been identified as substrates
for distinct members of two organic anion carrier gene fam-
ilies: the organic anion transporting polypeptide (OATP)
superfamily, classified within the solute carrier 21A gene
family (SLC21A) (16) and the organic anion transporter
(OAT) family, encoded by the solute carrier 22A (SLC22A)
genes (17). OATPs are multispecific transporters expressed
in many tissues, including the liver, brain, and placenta,
where they mediate the Na-independent uptake of a host
of organic anionic compounds. In particular, OATP-A
(SLC21A3) (18), OATP-B (SLC21A9) (19), the liver-specific
Abbreviations: CHO, Chinese hamster ovary; DAPI, 4-6-diamidino-2-
phenylindole; DHEA, dehydroepiandrostenedione; DHEAS, dehydroepi-
androsterone sulfate; E1, estrone; E1S, estrone 3-sulfate; E2, 17-estradiol;
IASD, acetamido-4-(iodoacetyl)amino-stilbene-2,2-disulfonic acid; Km, af-
finity constant; NEM, N-ethylmaleimide; OAT, organic anion transporter;
OATP, organic anion transporting polypeptide; PG, prostaglandin(s); SSC,
saline sodium citrate; Vmax, maximum velocity.
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OATP-C (SLC21A6) and OATP-8 (SLC21A8) (20, 21), OATP-E
(SLC21A12) (22), and OATP-F (SLC21A14) (23) have all
shown convincingly that they accept selected conjugated
steroids as substrates. Four isoforms of the OAT carrier fam-
ily have been characterized. Of these, OAT3 (SLC22A8) and
OAT4 (SLC22A11) mediate the cellular uptake of certain
steroid conjugates in the kidney, liver, brain, and placenta
(24–26).
Because the transport processes operative in mammary
tissue will govern the cellular entry of conjugated steroids,
it follows that individual carrier proteins may, in part, be
determinants of downstream estrogen exposure in target
cells. Accordingly, the identification and characterization of
the relevant transporters present in human mammary epi-
thelia deserve a detailed investigation. The aim of this study
was to identify and characterize the organic anion uptake
systems for conjugated steroids. Our findings show that
OATP-B (SLC21A9) may be the most functionally relevant
steroid sulfate carrier present and is able to account for de-
livery of both E1S and DHEAS to normal and tumor breast
tissue.
Materials and Methods
Materials
[6,7-3H]-E1S (53 Ci/mmol), [
3H]-DHEAS (60 Ci/mmol), and [3H]-
pregnenolone sulfate (389 mCi/mmol) were purchased from NEN Life
Science Products (Boston, MA). [5,6-3H]-PGE1 (48 Ci/mmol) was pur-
chased from Amersham Biosciences (Freiburg, Germany). [3H]-PGA1
was prepared by acid-catalyzed dehydration of [5,6-3H]-PGE1 and pu-
rified by thin-layer chromatography, as described by Andersen (27). All
cell culture media and reagents were obtained from Life Technologies
(Paisley, UK) or Sigma-Aldrich Chemie (Steinheim, Germany). Steroids
used in inhibition studies were obtained from Steraloids (Newport, RI);
prostaglandin (PG) A1 and A2 were purchased from Alexis Corporation
(Lausen, Switzerland); and unlabeled PGE, 2-cyclopenten-1-one, and
N-ethylmaleimide (NEM) were purchased from Sigma-Aldrich Chemie
(Steinheim, Germany). Acetamido-4-(iodoacetyl)amino-stilbene-2,2-
disulfonic (IASD) acid was purchased from Molecular Probes (Eugene,
OR). All other chemicals and reagents were of analytical grade and are
available from commercial sources.
RT-PCR
Expression of the known members of the OATP and OAT gene
superfamilies in normal human mammary tissue was studied by RT-
PCR assay. Reverse transcription was performed using total RNA (Clon-
tech, Palo Alto, CA) primed with Oligo(dT)15 as a template and AMV
Reverse Transcriptase (Promega, Wallisellen, Switzerland). PCR ampli-
fication used primers specific for each transporter (Table 1) and the
following conditions: one cycle of 95 C for 2 min; 40 cycles of 95 C for
45 sec; primer-specific annealing temperature for 45 sec; 72 C for 1 min;
and a final elongation of 72 C for 5 min. The primer-specific annealing
temperature was 50 C for OATP-A, OATP-C, OATP-D, OATP-E,
OATP-F, and OATP8, 58 C for hPGT, 63 C for OATP-B, and 55 C for all
OATs.
Northern blot analysis
Twenty micrograms of normal human mammary gland total RNA
(Clontech) per lane were loaded on a 1% agarose-formaldehyde gel.
After electrophoresis, the gel was washed three times for 10 min in 10
saline sodium citrate (SSC) and transferred overnight in 20 SSC to a
Hybond-NX (Amersham Biosciences) nylon membrane. The blot was
prehybridized for 30 min at 68 C in ULTRAhyb (Ambion, Austin, TX)
and hybridized overnight at 68 C in the same buffer with a 32P-labeled
antisense-RNA probe (nucleotides of the published sequences: OATP-A
nts 1959–2614, accession no. NM_134431; OATP-B nts 266–984, acces-
sion no. NM_007256; OATP-D nts 1742–1905, accession no. NM_013272;
OATP-E nts 1251–1551, accession no. NM_016354; OATP-F nts 1–545,
accession no. AF260704, with a specific activity of 1.4 counts per
minute  106/ml. The blots were washed twice for 5 min with 2
SSC/0.1% SDS at 68 C, twice for 15 min with 0.1 SSC/0.1% SDS at 68
C, and then exposed to autoradiography film at 70 C with an inten-
sifying screen, for 2 d for OATP-B and 5 d for OATP-A, OATP-D,
OATP-E, and OATP-F.
Immunohistochemistry
Breast tissue was obtained from routine biopsies evaluated by the
pathology department, sectioned at 10 m on a cryostat, fixed for 5 sec
in acetone at room temperature, air dried, and stored at 80 C. Sections
were postfixed for 12 min in 4% paraformaldehyde in PBS (pH 7.4) and
washed three times in PBS. Nonspecific binding was blocked for 30 min
with 10% normal goat serum/0.05% Triton in Tris-buffered saline. The
sections were incubated for 1.5 h at room temperature with an affinity-
purified OATP-B rabbit antiserum (28), diluted to an IgG concentration
of 70 g/ml in ChemMate diluent (DAKO, Glostrup, Denmark) with
0.05% Triton. Control experiments were performed by incubating sec-
tions with normal rabbit IgG and by preadsorption of the antiserum with
20 g/ml of the antigenic peptide. Sections were washed three times
with PBS, incubated for 30 min at room temperature with a Cy2-
conjugated F(ab)2 fragment goat antirabbit IgG (Jackson Immuno-
Research, West Grove, PA), diluted to 3 g/ml in DAKO ChemMate
diluent, then washed (three times) in PBS. Finally, sections were incu-
bated for 2 min in 5 mm 4-6-diamidino-2-phenylindole (DAPI), washed
with PBS, briefly rinsed with water, then mounted with fluorescent
TABLE 1. Detection of RT-PCR transcripts of the OATP and organic anion transporter gene superfamilies in normal human
mammary RNA
Gene Transporter Primer sequence forward (5 3 3) Primer sequence reverse (5 3 3) Transcript
OATPs
SLC21A3 OATP-A CTTCAGTTGTTGGAATAAATACC TTCACCAGGTAGATGACACTTCC 
SLC21A9 OATP-B CATGGGACCCAGGATAGGGCCAGCG GGCCTGGCCCCATCATGGTCACTG 
SLC21A6 OATP-C CAATCATGGACCAAAATCAACATTTG GGTTATGACTCCCAATAAGATGTTAG 
SLC21A11 OATP-D GCTGAGAACGCAACCGTGGTTCC GACTTGAGTTCAGGGCTGACTGTCC 
SLC21A12 OATP-E GCCATGCCACTGCAGGGAAATG TTCTGGTACACCAAGCAGGAGCCC 
SLC21A14 OATP-F CAGAAAGACAATGGATGTCC CACATCTTTTAAATCCCCATTTGAGGC 
SLC21A8 OATP8 GAATAAAACAGCAGAGTCAGCATC GCAATATAGCTGAATGACAGG 
SLC21A2 PGT CCGCAGGGACTGCTCGT CGCATCAACAAGAACTGCACC 
OATs
SLC22A6 OAT1 CATCTACCATCGTGACTGAGTGG CCTCCATACTCAATTTGGCTCCTTC 
SLC22A7 OAT2 GAGTACGACCACTCAGAATTCTCC GGAACAGGTCTAGGTATGAAGGTC 
SLC22A8 OAT3 GTTCCTGCATGTAGCCATACTGG GCAGAATGAACTGGCCAAAGGTG 
SLC22A11 OAT4 CTCTGCGGTTTCCACAAACATGACC CCACCATCAGTGTCAGTGAACTCAG 
RT-PCR was performed using total RNA from normal mammary gland as a template. Primers and PCR conditions specific for each transporter
are described in Materials and Methods. (), Transcript present; (), no transcript detectable.
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mounting medium (DAKO) and examined by confocal laser scanning
microscopy (Leica, Wetzlar, Germany). For double-labeled immunoflu-
orescence, one of the following primary antibodies was included: mouse
monoclonal antihuman cytokeratin AE1/AE3 (DAKO), 1.74 g/ml;
mouse monoclonal antihuman calponin Ab-1, clone CALP (NeoMark-
ers, Fremont, CA), 2 g/ml; or mouse monoclonal antihuman Ki-67
antigen, clone MIB-1 (DAKO), 700 g/ml. The Alexa Fluor 647-conju-
gated F(ab)2 fragment of goat antimouse IgG (Molecular Probes, Eu-
gene, OR), 2.5 g/ml, served as the secondary antibody.
Stable transfection of OATP-B in CHO-K1 cells
Chinese hamster ovary (CHO)-K1 cells were cultured in DMEM (Life
Technologies) supplemented with 10% fetal calf serum, 2 mmol/liter
l-glutamine, 50 g/ml l-proline, 100 U/ml penicillin, and 100 g/ml
streptomycin at 37 C with 5% CO2 and 95% humidity. Selective medium
contained 500 g/ml G418 sulfate (Life Technologies). The OATP-B
open reading frame, originally cloned from human brain (19), was di-
rectionally subcloned into the pIRESneo2 (Clontech) expression vector
and transfected into CHO-K1 wild-type cells by electroporation as fol-
lows: subconfluent CHO-K1 cells were trypsinized and resuspended in
cell culture medium. Approximatively 107 cells were transferred to a
0.4-cm Gene Pulser cuvette (Bio-Rad, Hercules, CA), mixed with 20 g
plasmid and incubated for 10 min on ice before electroporation using a
single electrical pulse with an initial field strength of 250 V, discharged
from the 960-F capacitor (Bio-Rad). After a 10-min incubation on ice,
the cells were plated on 10-cm culture dishes, then selected in G418 (1000
g/ml). Single clones were isolated from the transfected cell pool using
cloning cylinders and tested for sodium-independent E1S uptake. The
clone with the highest transport activity was selected.
For immunofluorescent detection of OATP-B in stably transfected
CHO-K1 cells grown on glass coverslips, sodium butyrate (5 mmol/
liter) was added to the culture medium for 24 h. Cells were fixed in 4%
paraformaldehyde for 1 h, permeabilized for 10 min with saponin (0.1%)
in PBS, and blocked with gelatin (2%) and BSA (1%) in PBS containing
0.1% saponin for 40 min, then incubated with OATP-B antiserum, di-
luted to 6 g IgG per milliliter in PBS with 0.1% saponin and 1% BSA.
The Cy2-conjugated F(ab)2 fragment goat antirabbit secondary anti-
body was diluted in PBS with 1% BSA.
Transport assays
The uptake of radiolabeled substrates in OATP-B transfected CHO
cells was measured in triplicate, as follows: cells were grown to con-
fluency on 35-mm dishes and stimulated for 24 h with 5 mmol/liter
sodium butyrate (29). Individual dishes were rinsed three times with
prewarmed (37 C) uptake buffer consisting of 116 mmol/liter NaCl, 5.3
mmol/liter KCl, 1 mmol/liter NaH2PO4, 0.8 mmol/liter MgSO4, 5.5
mmol/liter d-glucose, and 20 mmol/liter HEPES (pH 7.4). Uptake ex-
periments were performed in 800 l solution containing 0.2–0.3 Ci
tritiated substrate supplemented with unlabeled compound to reach the
indicated concentrations. Transport was stopped with 2 ml of ice-cold
buffer (116 mmol/liter choline Cl, 5.3 mmol/liter KCl, 1 mmol/liter
KH2PO4, 0.8 mmol/liter MgSO4, 5.5 mmol/liter d-glucose, and 20
mmol/liter HEPES), followed by three additional washes. The cells were
solubilized in 1 ml of 1% Triton, and the radioactivity was measured by
liquid scintillation counting. Specific OATP-B-mediated uptake was de-
termined by subtracting values from identical experiments conducted in
wild-type CHO cells.
Real time quantitative PCR
Total RNA was extracted from the breast cancer cell line T-47D
(American Type Culture Collection, Manassas, VA), CHO-K1 wild-type
cells, and OATP-B stable transfected CHO cells using the TRIzol Reagent
(Life Technologies). Additional RNA from the breast cell lines MCF-7
and MDA-MB-453 and the hepatocyte cell line Hep-G2 was purchased
from Ambion, Inc. (Austin, TX). Reverse transcription of 2 g total RNA
was performed with random hexamer primers and 125 U reverse tran-
scriptase (MultiScribe, Applied Biosystems, Rotkreuz, Switzerland). An
aliquot (50 ng) was used as a template for real-time PCR (TaqMan, ABI
PRISM 7700 Sequence Detector, Applied Biosystems). Primers and the
VIC dye-labeled probe for 18S ribosomal RNA, which served as the
internal control, were provided by Applied Biosystem. The primers and
probe that detected OATP-B have been characterized previously (28):
forward primer 5-AGGACGTGCGGCCAAGT-3, reverse primer 5-
TCTTTAGGTAGCCGGAGATCATG-3, FAM/TAMRA-labeled probe
5-CATCAAGCTGTTCGTTCTGTGCCACA-3. To detect OATP-D, the
following were designed: forward primer 5-GGTGTCCACTGCTTGC-
TACGT-3, reverse primer 5-TCGGTTTGGCATTCACAGTTATT-3,
FAM/TAMRA-labeled probe 5-AACAGCACAGCACCTGGCTCA-
GCC-3. To detect OATP-E, the following were designed: forward
primer 5-GCGAGCAACCCGGACTT-3, reverse primer ACATGCCG-
GTGATGAGAGTG-3, FAM/TAMRA-labeled probe 5-AGACCTGC-
CTCTCTCCATCTGGCTCC-3.
Results
Detection of OATs in human mammary gland by RT-PCR
and Northern blot analysis
RT-PCR of total RNA from normal mammary gland de-
tected transcripts for the following carriers: OATP-A,
OATP-B, OATP-D, OATP-E, and OATP-F. The liver-specific
carriers, OATP-C and OATP-8, and the related PG trans-
porter (SLC21A2) were not present, nor was expression of
transporters belonging to the OAT family detected (Table 1).
Subsequent Northern blot analyses (Fig. 1) confirmed the
presence of OATP-B, which showed a major hybridization
signal at 4 kb and a minor band at 1.7 kb after 2 d of exposure.
OATP-D and OATP-E showed weaker signals at 3.8 kb and
3.3 kb, respectively, but required exposure for 5 d. Signals for
OATP-A and OATP-F could not be detected by Northern
blotting, suggesting a very low abundance.
Immunofluorescent localization of OATP-B in the
mammary gland
Because of the apparent abundance at the RNA level rel-
ative to the other carriers tested, OATP-B was chosen for
further characterization. OATP-B was immunolocalized in
frozen sections from biopsy material. In tissue with normal
appearance, cut from the edges of tumor regions, the
OATP-B immunolabeling was weak and discontinuous, and
FIG. 1. Northern blot analysis of OATP expression in human breast
tissue. Twenty micrograms of total RNA from normal mammary
gland were transferred to a nylon membrane and hybridized over-
night with a specific antisense-RNA probe for OATP-A (A), OATP-B
(B), OATP-D (D), OATP-E (E), and OATP-F (F), as described in Ma-
terials and Methods. Blots were washed with high stringency and
exposed to autoradiographic film at 70 C for 2 d (OATP-B) or 5 d
(OATP-A, OATP-D, OATP-E, OATP-F).
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confined to the membranes of the external cell layer that
surround the ductules (Fig. 2A). Control sections incubated
with the preadsorbed OATP-B antibody were negative (Fig.
2B). Normal ductal epithelial cells did not show a signal.
Morphologically, the cells displaying the positive OATP-B
signal were characteristic of the contractile myoepithelial
cells that line the ducts of the mammary gland. Double la-
beling with an antibody to calponin, a smooth muscle cell-
specific protein that is a differentiation marker for myoep-
ithelial cells of the breast (30), confirmed the colocalization
of calponin and OATP-B to the same cell type (Fig. 2, C–E).
In tumor-bearing tissue, OATP-B was most apparent in areas
of invasive ductal carcinoma, where it was localized to the
membrane of cytokeratin-positive epithelial cells (Fig. 2, F
and G) but lost its association with myoepithelial cells (Fig.
2H). OATP-B also retained its membrane expression in neo-
plastic cells that displayed a positive reaction to the Ki-67
antigen, an indicator of cells in an active proliferating state
(Fig. 2I).
Immunolocalization and transport activity of recombinant
OATP-B in transfectants
To confirm the membrane expression of OATP-B in stably
transfected CHO cells, we immunolocalized the protein after
induction of transcription with sodium butyrate. The uni-
form, positive surface staining indicated marked expression
at the plasma membrane (Fig. 3). Wild-type cells were neg-
ative (data not shown).
OATP-B mediates E1S uptake when expressed in oocytes
(19) and in HEK293 cells (31) with affinity constant (Km)
values estimated to be 4–6 mol/liter. However, the assign-
ment of DHEAS as a substrate is equivocal, and the extent of
its interaction with other steroids has not been investigated.
The validity of the OATP-B stably transfected CHO expres-
sion system was first tested for E1S. Uptake was linear for
20 sec (Fig. 4A) and saturable with an apparent Km value of
5 mol/liter and a maximum velocity (Vmax) value of 777
pmol/mg proteinmin (Fig. 4B). In cis-inhibition studies with
5 mol/liter [3H]-E1S, DHEAS showed a dose-dependent
effect that reached statistical significance at 50 mol/liter
(Fig. 5A). Another adrenally derived steroid hormone pre-
cursor, pregnenolone sulfate, was a more potent inhibitor
and significantly inhibited E1S uptake to 50% and 20% of
control values at 10 mol/liter and 50 mol/liter, respec-
tively. Other pregnenolone derivatives, 17-OH pregnenolone
sulfate and 21-OH pregnenolone sulfate, inhibited uptake to
a moderate degree at the higher concentration tested (Fig.
5B). The unconjugated forms of pregnenolone, 17-OH preg-
nenolone and 21-OH pregnenolone, exerted no effect when
tested at 10 mol/liter (data not shown).
The inhibition by DHEAS and earlier findings that OATP-
B-injected oocytes displayed a 1.6-fold signal over control
oocytes (19) imply that DHEAS is a weak substrate for this
carrier. Because of the importance of DHEAS as an estrogen
precursor, the uptake of [3H]-DHEAS was reevaluated in the
OATP-B expressing CHO cells. A significant uptake rate was
measurable and showed linearity for 40 sec (Fig. 6A). Nev-
ertheless, the OATP-B-specific signal was weak and dis-
played large variations when the difference (uptakeOATP-B 
uptakewild-type) was calculated (Fig. 6B). To confirm that
DHEAS uptake in OATP-B-transfected CHO cells was car-
rier-mediated over a broad concentration range, equation 1,
describing saturable Michaelis-Menten kinetics with a non-
FIG. 2. Immunolocalization of OATP-B in human mammary gland.
Cryosections (10 m) of grossly normal tissue from areas adjacent to
an invasive carcinoma (A–E) and sections of invasive carcinoma (F–I)
were incubated with primary antibodies and Cy2- or Cy5-conjugated
secondary antibodies and examined by confocal scanning microscopy.
A, Staining for OATP-B is restricted to the outer cell layer that
surrounds the ducts. B, Control slide incubated with OATP-B pread-
sorbed with the antigenic peptide. C–E, Colocalization of OATP-B
(Cy2, green) and calponin (Cy5, red). C, There is a discontinuous
signal for OATP-B (green) in the membranes of cells surrounding the
ductules. D, An intense signal for calponin (red) identifies the myo-
epithelial cells. E, OATP-B and calponin produce an overlapping
signal (yellow). Nuclei are counterstained with DAPI (blue). F and G,
Poorly differentiated invasive ductal carcinoma expresses OATP-B
(Cy2, green) (F) in the membranes of cytokeratin-positive epithelial
cells (Cy5, red) (G). Nuclei are counterstained with DAPI (blue). H,
OATP-B (Cy2, green) is expressed in an invasive lobular tumor. The
occasional stromal myofibroblast stains for calponin (Cy5, red). I,
Invasive ductal carcinoma with actively proliferating neoplastic cells
staining positive for Ki67 nuclear antigen (Cy5, red). OATP-B (Cy2,
green) is expressed in the proliferating cells. Nuclei are counter-
stained with DAPI (blue).
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saturable first-order process, and equation 2, which describes
simple nonsaturable first-order kinetics, were curve-fitted to
the data.
 
Vmax  S
Km  S
 P  S (1)
  P  S (2)
where  is the initial rate of uptake (pmol/minmg), [S] is the
substrate concentration (mol/liter), and P represents a first-
order clearance term (l/minmg). The background signal in
wild-type CHO cells was well described by equation 2. Total
DHEAS uptake in OATP-B transfectants was best described
by a saturable component plus a first-order process (equation
1) (Fig. 6B). The statistical improvement of the curve fit of
equation 1 over equation 2 was assessed by the F test (F 
0.01). The estimated Km and Vmax values calculated in this
way were 9 mol/liter and 85 pmol/minmg, respectively,
consistent with the fact that OATP-B has moderate affinity
but low capacity for DHEAS. Conversely, no OATP-B-
mediated uptake of [3H]-pregnenolone sulfate could be iden-
tified (data not shown), despite the strong inhibition of E1S
transport by this steroid (Fig. 5).
The interaction of OATP-B and PG
Additional physiological substrates of OATP-B could in-
fluence the extent of steroid sulfate uptake in mammary
tissue. OATP-B shares 76% identity with the PG transporter
(SLC21A2), and other more distantly related members of the
solute carrier family 21A, such as OATP-C, do transport PG
(21). PGE2 is especially relevant as a potential substrate for
OATP-B because high intratumoral levels are achieved via
the cyclooxygenase pathway that is up-regulated in tumors
relative to the surrounding normal tissue (32). The role of
OATP-B in PG transport was reevaluated in the stable-trans-
fected CHO cells. Neither PGE1 nor PGE2 inhibited [
3H]-E1S
uptake (Fig. 7A). Additional experiments with radiolabeled
PGE1 and PGE2 confirmed that OATP-B did not mediate the
uptake of PG (data not shown). Unexpectedly, the naturally
occurring cyclopentenone PGA1, which is derived from
PGE1, increased OATP-B-mediated [
3H]-E1S transport (Fig.
7A). The PGA1-mediated stimulation was detectable after
15 sec and was maximal at 1 min (Fig. 7B). No further stim-
ulation occurred when transport was measured at longer
intervals or when cells were preincubated with PGA1 (data
FIG. 4. Time course (A) and saturation kinetics (B) of OATP-B-
mediated E1S uptake into stably transfected CHO-K1 cells. A, After
a 24-h incubation in 5 mmol/liter sodium butyrate, wild-type CHO
cells (E) or OATP-B-expressing CHO cells (F) were incubated with 5
mol/liter [3H]-E1S at 37 C for the indicated times. Data points rep-
resent means  SD of triplicate determinations. B, Wild-type (E) or
OATP-B transfected (F) CHO cells were incubated with increasing
concentrations of [3H]-E1S at 37 C for 15 sec. Net OATP-B-mediated
uptake (dashed line) was calculated by subtracting the values of the
wild-type cells from those obtained with the OATP-B transfected cells
(means  SD of three determinations). The data were fitted to the
Michaelis-Menten equation using nonlinear regression analysis.
FIG. 3. Immunofluoresence of recombinant OATP-B in sta-
bly transfected CHO cells. Wild-type control CHO cells or
OATP-B expressing CHO cells were grown on coverslips
and incubated for 24 h with 5 mmol/liter sodium butyrate.
Sections were stained with an affinity-purified OATP-B-
specific antibody and a Cy2-conjugated secondary antibody.
A, OATP-B was expressed at the plasma membrane. B,
Differential interference contrast of cells shown in A.
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not shown). A more marked stimulation was observed at
lower substrate concentrations (500 nmol/liter) with both
100 nmol/liter and 1 mol/liter (Fig. 7B). PGA2, a second
cyclopentenone prostanoid derived from PGE2, also en-
hanced E1S uptake at similar concentrations. However, PGJ2,
a third cyclopentenone PG, which differs from the PG of the
A series by the position of the reactive electrophilic carbon,
had no effect (Fig. 7C). The PGA1 and PGA2 stimulation of
transport was also manifest with DHEAS and to the same
extent (an increase of 100% 5 and 100% 10 for PGA1 and
PGA2, respectively) (Fig. 7D).
To further characterize the PGA-stimulated steroid sulfate
transport, the estimation of kinetic parameters was repeated
in the presence of 1 mol/liter PGA1. There was no differ-
ence in the Km value for either substrate, but the Vmax in-
creased by 2-fold for DHEAS (from 85  20 to 166  19
pmol/minmg) and 1.5-fold for E1S (from 777  45 to 1191 
36 pmol/minmg). To determine whether PGA was a sub-
strate for OATP-B and able to effect stimulation of transport
from the trans-side of the cell, we measured the time-depen-
dent uptake of [3H]-PGA1. No OATP-B-mediated uptake of
PGA1 occurred (Fig. 8A). However, a significant signal was
evident with both the OATP-B transfectants and wild-type
cells, which could represent an element of membrane bind-
ing of the radiolabel.
FIG. 5. cis-Inhibition of OATP-B-mediated E1S uptake by steroid sul-
fates in stably transfected CHO cells. Wild-type (WT; f) and OATP-
B-transfected (u) CHO cells were grown to confluency on 35-mm
dishes and incubated for 24 h in 5 mmol/liter sodium butyrate. Five
micromoles per liter of [3H]-E1S uptake at 37 C were measured in the
absence (control) or presence of inhibitors. Data represent the
means  SD of triplicate determinations. *, P  0.02. A: 1, Control; 2,
DHEAS, 10 mol/liter; 3, DHEAS, 50 mol/liter; 4, pregnenolone
sulfate, 10 mol/liter; 5, pregnenolone sulfate, 50 mol/liter. B: 1,
Control; 6, 21-hydroxy-pregnenolone sulfate, 10 mol/liter; 7, 21-
hydroxy-pregnenolone sulfate, 50 mol/liter; 8, 17-hydroxy-preg-
nenolone sulfate, 10 mol/liter; 9, 17-hydroxy-pregnenolone sulfate,
50 mol/liter.
FIG. 6. Time course (A) and saturation kinetics (B) of OATP-B-
mediated DHEAS uptake into stably transfected CHO cells. A, After
a 24-h incubation in 5 mmol/liter sodium butyrate, wild-type CHO
cells (E) or OATP-B expressing CHO cells (F) were incubated with 100
nmol/liter [3H]-DHEAS at 37 C for the indicated times. Data points
are means  SD of triplicate determinations. B, Wild-type (E) or
OATP-B-transfected (F) CHO cells were incubated with increasing
concentrations of [3H]-DHEAS at 37 C for 30 sec. Data were fitted by
nonlinear regression to a model comprising a saturable and first-order
component (see equation 2).
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The stimulation by PGA1 and PGA2 and not PGE1 and
PGE2 suggests that the cyclopentenone moiety of the com-
pound with its ,-unsaturated carbonyl group (Fig. 9), is a
key determinant of this activity. Accordingly, cyclopen-
tenone (2-cyclopenten-1-one) itself should mimic the effect of
PGA. To test this, E1S uptake was measured in the presence
of 50 mol/liter and 100 mol/liter cyclopentenone, which
resulted in a 1.3-fold and 1.5-fold increase, respectively, in
the signal (Fig. 8B). This suggests that the mechanistic basis
for the PGA stimulation is the chemical reactivity of the
cyclopentenone ring. In particular, the electrophilic C11 of
PGA1 and PGA2 (Fig. 9) is susceptible to addition reactions
with nucleophiles such as the free sulfhydryl group of cys-
teine residues (33). To investigate whether Cys residues in
the OATP-B protein may be target sites for the actions of
PGA1 and PGA2, transport studies were performed in the
presence of thiol reagents. Cells pretreated with 100 mol/
liter of the membrane-permeable NEM showed a 40% de-
crease in E1S uptake, suggesting that one or more Cys res-
idues are involved in substrate binding and/or transport
(Fig. 8C). In NEM-pretreated cells, the PGA1 stimulation was
completely abrogated. This supports the notion that an in-
teraction with cysteine residues regulates the actions of
PGA1. Additional experiments with the membrane imper-
meable, polar sulfhydryl reagent IASD at 500 mol/liter,
which accesses only those Cys residues within a hydrophilic
FIG. 7. Effect of PG on OATP-B-mediated E1S (A–C) and DHEAS (D) uptake. Wild-type (WT) or OATP-B-transfected CHO cells were grown
to confluency on 35-mm dishes and incubated for 24 h in 5 mmol/liter sodium butyrate. Uptake of 5 mol/liter (A), 0.5 mol/liter (B and C) [3H]-E
1S or 0.5 mol/liter [
3H]-DHEAS (D) was measured at 37 C for 1 min. Data are the means  SD of triplicate determinations. *, P  0.02. A,
5 mol/liter [3H]-E1S in the absence (control) or presence of PGE1, 10 mol/liter; PGE2, 10 mol/liter; or PGA1, 10 mol/liter. B, Fifteen-second
or 1-min uptake of 0.5mol/liter [3H]-E1S in the absence (control) or presence of PGA1, 1mol/liter or 0.1mol/liter, respectively. C, One-minute
uptake of 0.5 mol/liter [3H]-E1S in the absence (control, 1) or presence of 1 mol/liter PGA1 (2), 1 mol/liter PGA2 (3), 0.1 mol/liter PGA2
(4), or 1 mol/liter PGJ2 (5). D, One-minute uptake of [
3H]-DHEAS in the absence (control, a) or presence of 1 mol/liter PGA1 (b), 0.1 mol/liter
PGA1 (c), 1 mol/liter PGA2 (d), or 0.1 mol/liter PGA2 (e).
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environment, supported this view. E1S uptake was equally
sensitive to the presence of IASD as with NEM (Fig. 8C).
However, a 2-fold stimulation with PGA1 was still possible,
in keeping with the hypothesis that the Cys residues reacting
with PGA are inaccessible to the hydrophilic IASD but are
nevertheless blocked by NEM.
The presence of OATPs in breast cancer cell lines
To establish whether widely used breast cancer cell lines
expressed OATP carriers and could serve as in vitro models
for additional studies of steroid sulfate transport, the mRNA
expression of OATP-B, OATP-D, and OATP-E was measured
in MCF-7, T47D, and MDA-MB-453 cell lines. For compar-
ison, the expression levels in the OATP-B stably transfected
CHO cells as well as in the Hep-G2 cell line, which reportedly
expresses both OATP-B and OATP-E (34), are given. None of
the breast cancer lines examined gave detectable signals for
OATP-B above background levels (Table 2). Conversely,
when standardized for expression in Hep-G2 cells, our stud-
ies identified MCF-7 as the cell line with the highest expres-
sion of OATP-E (13-fold higher than Hep-G2), whereas the
MDA-MB-453 and T47-D cell lines express 10-fold and 100-
fold less, respectively. Although no standard cell line was
after 1 min at 37 C. Cyclopentenone at 50 mol/liter and 100 mol/
liter significantly stimulated transport compared with control con-
ditions (no cyclopentenone). C, The effect of thiol reagents on PGA
stimulation of OATP-B transport. E1S uptake was measured at 1 min
in wild-type (f) and OATP-B transfectants (u) in the absence (bars
1, 3, and 5) and presence of PGA1 1 mol/liter (bars 2, 4, and 6). The
membrane permeable thiol reagent, NEM (bars 3 and 4) inhibited
substrate binding and/or transport. The effect of PGA1 (bar 4) was
blocked. The hydrophilic thiol reagent, IASD acid, also inhibited
transport (bars 5 and 6), but transport was stimulated 2-fold by PGA1
(bar 6). Data are mean  SD of triplicate determinations.
FIG. 8. Interaction of PGA with OATP-B. A, [3H]-PGA1 was tested as
a substrate for OATP-B in wild-type CHO cells (E) and OATP-B
transfectants (F) after stimulation for 24 h with sodium butyrate.
Uptake was measured at 37 C for 1 min and 5 min. B, The effect of
the cyclopentenone moiety of PGA on OATP-B-mediated E1S uptake.
Wild-type CHO (WT) cells (f) and OATP-B transfectants (u) were
incubated with cyclopentenone, and uptake of [3H]-E1S was measured
FIG. 9. Cyclopentenone PG. PGA1 and PGA2 both contain the cyclo-
pentenone ring structure. The electrophilic carbon (C11) is indicated.
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available for OATP-D, MCF-7 again expressed the highest
levels of OATP-D mRNA (approximately 100-fold more than
T47-D and 500-fold more than MDA-MB-453) (Table 2).
Discussion
OATP-B appears to be one of the most abundant organic
anion uptake carriers expressed in the human mammary
gland. Generally, OATP family members exhibit broad sub-
strate specificity, encompassing bile salts, sulfate, and gluc-
uronide conjugates of endogenous and exogenous com-
pounds, anionic peptides, and even cations in some cases
(16). OATP-B is peculiar in that its substrate list is restricted,
despite its expression in a broad range of tissues (22). The
transport of E1S remains the best characterized function for
this carrier and may represent its true physiological role in
the mammary gland.
At the protein level, the expression of OATP-B in normal
mammary tissue was confined to the myoepithelium. Myo-
epithelial cells have contractile properties required for lac-
tation and can elaborate extracellular matrix proteins, such
as collagen and laminin, that are needed to maintain polarity
in the adjacent ductal epithelial cells (35). The current find-
ings identify OATP-B as a steroid sulfate carrier in the myo-
epithelium. In view of the recent report that marked steroid
sulfatase activity is also present in isolated myoepithelial
cells (36), it is tempting to speculate that these cells engage
in intercellular cross-talk to supply desulfated hormones to
adjacent target cells. OATP-B is also expressed in the epi-
thelia of invasive ductal carcinomas, which are characterized
in part by the absence of myoepithelial cells. In these sections,
expression was marked in the majority of tumor cells, in-
cluding those in an active proliferating state. The presence of
a steroid sulfate carrier in tumor cells could be a previously
unrecognized factor, together with the elevated expression
levels of the 17-hydroxysteroid dehydrogenase type 1 and
aromatase enzymes (12, 37), that contributes to the high
intratumor levels of E2 reported in some cases. The influence
of OATP-B in determining the estrogen level of target cells
will, nevertheless, be tempered by the multidrug resistance
protein MRP1, the expression of which in epithelial cells of
normal and tumoral breast tissue has been documented (34,
38, 39). MRP1 can export E1S (40), and, considering the high
variability in expression levels detected in cancer patients
(38, 39), it could have an unpredictable influence on the status
and relevance of OATP-B in breast tumors.
Independent of the eventual conversion to E2, DHEA itself
may exert biological actions on mammary tissue, both on
transcription events and through signal transduction mech-
anisms. There is evidence that DHEA contributes to estrogen
receptor-dependent trans-activation of transcription (41, 42),
and DHEA can inhibit vascular smooth muscle cell prolif-
eration through an inhibition of phosphorylation signal-
ing (43).
Pregnenolone sulfate, an adrenal steroid that serves as a
precursor for DHEA and progesterone, achieves circulating
concentrations of approximately 1 mol/liter (44). There is
some evidence that the enzymatic pathway from preg-
nenolone to 17-hydroxypregnenolone to DHEA and andro-
stenedione is intact in human breast tissue (45) and that
pregnenolone sulfate can accumulate in fibrocystic breast
cyst fluid in concentrations up to 20 times greater than in
serum (46). In light of previous findings that pregnenolone
sulfate could inhibit OATP-B-mediated E1S uptake in an
oocyte expression system and in basal membrane vesicles
isolated from placental syncytiotrophoblast (28), we specu-
lated that OATP-B may be a broad-spectrum steroid sulfate
carrier and could accept such a relevant steroid hormone
precursor. Despite the clearly evident interaction of preg-
nenolone sulfate with the OATP-B carrier to inhibit E1S trans-
port, it is not a substrate. Therefore, OATP-B remains a se-
lective carrier but one that is susceptible to inhibition by other
physiological steroids.
The finding that PGA1 and PGA2 can stimulate OATP-B-
mediated uptake implies that E1S and DHEAS cellular entry
can be regulated locally at the plasma membrane, possibly
with downstream consequences of increased hormone ex-
posure in target cells. PGE2 is a product of arachidonic acid
metabolism and is secreted by breast tumor cells as well as
stromal cells (47–49). Its formation is catalyzed by cycloox-
ygenase 2, an enzyme up-regulated in breast cancer tissue.
PGA1 and PGA2 arise from the dehydration of PGE1 and
PGE2, respectively, both intracellularly and in the circulation.
It follows that PGA1 and/or PGA2 are physiologically rele-
vant and available for interaction with the OATP-B carrier.
The mode of this interaction requires detailed study, but the
present findings emphasize that the reactive cyclopentenone
ring and cysteine residues are critical elements (Fig. 8, B and
C). PGA can form adducts with selected proteins: PGA1
covalently binds to IB kinase to inhibit the phosphorylation
of IB (50), and PGA2 binds covalently to Cys 47 of the
TABLE 2. Real-time quantitative PCR of OATP carriers in human mammary cancer cell lines
Cell line
OATP-B OATP-E OATP-D
	Cta OATPB-18S Relative levelb 	Cta OATPE-18S Relative levelc 	Cta OATPD-18S
Cell line
CHO(OATP-B) 10.5  0.06 100  2%
MCF-7 ND 11.5  0.2 1380  44% 15.5  0.2
MDA-MB-453 ND 18.6  0.2 10  3% 24.4  0.6
T47-D ND 24.8  0.1 0.14  0.004% 21.7  0.1
Hep-G2 16.8  0.5 1.2  0.4% 15.3  0.3 100  30%
Data are mean  SD of triplicate measurements. ND, Not detected.
a The data were calculated by subtracting the signal threshold cycles (Ct) of the internal standard (ribosomal 18S) from the Ct of the target
gene (OATP-B, OATP-E, OATP-D).
b Values were normalized to the expression level of OATP-B transfected CHO, set to 100%.
c Values were normalized to the expression level of Hep-G2 cells, set to 100%.
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glutathione S-transferase P1 isozyme (51). Therefore, a re-
action between PGA1/PGA2 and one or more cysteine res-
idue of OATP-B can be counted as a plausible mechanism but
one that must accommodate a resulting increase in activity
rather than a decrease. As with the other members of the
human OATP superfamily, OATP-B has several Cys residues
within the purported extracellular domains (16). It is likely
that one or more are important for substrate binding and
transport because E1S uptake is sensitive to the thiol reagents,
NEM and IASD. PGA1 remains effective in the presence of
the impermeable IASD, suggesting that PGA1 is acting at a
distinct site, inaccessible to the hydrophilic reagent but vul-
nerable to the more lipophilic PG. The mechanism by which
the proposed PGA1-OATP-B interaction stimulates transport
has not been addressed here. One reasonable hypothesis
involves consideration of the quaternary structure of this
integral membrane protein. OATP-B has 12 putative
membrane-spanning domains, a characteristic it shares with
all members of the solute carrier family SLC21A (16). Other
membrane transporters with a similar 12 trans-membrane
domain structure, such as glucose transporter type 1 belong-
ing to the SLC2A solute carrier family and the serotonin and
dopamine transporters that are members of the SLC6A fam-
ily, form oligomers mediated by disulfide bonds. A change
in the state of oligomerization carries functional conse-
quences (52, 53). If OATP-B shares these biochemical fea-
tures, it is possible that PGA could intervene at critical Cys
residues to induce a more favorable oligomeric structure.
OATP-B was not expressed in three widely used, pheno-
typically characterized breast cancer cell lines (Table 2). This
precludes their fortuitous use as model cell lines in which to
conduct additional regulatory studies against backgrounds
of varying steroid hormone receptor levels and metabolic
pathways. The lack of OATP-B notwithstanding, both MCF-7
and T47-D cells respond positively to exposure to E1S and
DHEAS, with changes in downstream metabolites and
growth (4, 54, 55). The fact that both cell lines express
OATP-D and OATP-E to some degree (Table 2) and that E1S
is listed as a weak substrate for both of these carriers (22)
could account for this. Whether OATP- D and OATP-E have
a role in determining steroid hormone levels in human breast
tissue has yet to be examined.
The perceived risk of estrogen exposure in the genesis and
progression of breast cancer is strong. In light of the current
findings, additional studies that specifically address 1) the
comparative expression of OATP-B in breast tumors and
normal tissue and 2) the possible coordinate regulation of
this carrier with enzymes that metabolize precursors to
downstream, biologically active hormones, are warranted.
Moreover, the possibility that the interaction with PG of the
A series constitutes a point of regulation for the actions of
OATP-B in breast tissue merits further consideration.
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